跳转至内容
Merck
CN

UHPLC/MS Analysis of Anticonvulsants on Ascentis® Express HILIC

UHPLC/MS Analysis of Anticonvulsants on Ascentis® Express HILIC application for UHPLC-MS

材料

相关产品

产品编号
说明
价格

Ascentis® Express HILIC, 2.7 μm HPLC色谱柱

2.7 μm particle size, L × I.D. 10 cm × 3 mm

加巴喷丁标准液 CRM 溶液

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Pregabalin solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Vigabatrin solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

CONDITIONS

column

Ascentis Express HILIC, 10 cm x 3.0 mm I.D., 2.7 μm particles (53970-U)

mobile phase

[A] 5 mM ammonium formate pH unadjusted in 95:5, acetonitrile:water; [B] 5 mM ammonium formate pH unadjusted in 75:25, acetonitrile:water; (25:75, A:B)

flow rate

0.4 mL/min

pressure

1240 psi (85.5 bar)

column temp.

35 °C

detector

MS-ESI-, full scan 100-500 m/z

detector

5 μL

sample

3 anticonvulsants 1 μg/mL in 99:1, acetonitrile:methanol

说明

分析说明

The unique selectivity of the Ascentis Express HILIC phase provided rapid LC/MS resolution of these anticonvulsant compounds. The highest grade LC-MS solvents were used to supply low background interference and low particulate contaminants for robust, trouble-free operation. Cerilliant CRMs provided reliable identification and quantification.

法律信息

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany